A district consumer court in Uttarakhand on Wednesday found Dr Lal Pathology Lab "grossly negligent" in not providing a report of the first sample and misplacing second sample of a patient who was ...

According to The Telegraph report Khelif the 26-year-old was found to have male XY chromosomes in a 2023 following the test conducted by Dr. Lal Path Labs in New Delhi, India.

The Delhi State Consumer Disputes Redressal Commission reaffirmed that Dr Lal Pathlabs was deficient in service, ordering ...

However, Dr. Lal PathLabs did not specify if it raised prices of its tests. The company's revenue from operations increased 10% to 6.6 billion rupees, beating analysts' estimates of 6 billion rupees.

Dr Lal PathLabs has registered a 81.4% quarter-on-quarter (QoQ) surge in its net profit in Q4 FY25, exceeding expectations. The net profit of the consolidated company in the quarter was ₹155 ...

Dr Lal Path Labs: The company benefited from strong demand for its bundled tests offerings, which combine tests for multiple conditions, such as diabetes and thyroid, under one, analysts said.

India's Dr Lal Path Labs reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3% higher.

According to The Telegraph report Khelif the 26-year-old was found to have male XY chromosomes in a 2023 following the test conducted by Dr. Lal Path Labs in New Delhi, India.

Dr Lal Path Labs, India's largest diagnostics firm by revenue, reported fourth-quarter profit above expectations on Friday as strong demand for its bundled test packages lifted growth amid rising ...

India's Dr Lal Path Labs reported a 19% jump in its third-quarter profit on Thursday, led by continued demand for its bundle test offerings, sending its shares 3% higher. The company's consolidated ...

Dr Lal Path Labs: The company's consolidated net profit rose to 967 million rupees ($11.2 million) in the three months to Dec. 31, from 813 million rupees a year earlier, but fell short of ...